Last reviewed · How we verify
NCT04083742
The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study
trial testing ANTERION in Narrow Angle in 59 participants. Completed in 31 December 2023.
15 November 2023
Quick facts
| Lead sponsor | Heidelberg Engineering GmbH |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 59 |
| Start date | 22 August 2019 |
| Primary completion | 15 November 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- ANTERION
Conditions studied
- Narrow Angle — all drugs for Narrow Angle →
- Open Angle — all drugs for Open Angle →
Sponsor
Heidelberg Engineering GmbH
Who can join
22 and older, any sex, with Narrow Angle or Open Angle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment metrics with the ANTERION
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04083742
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ANTERION
Trials testing the same drug.
- NCT05051813 — The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study · completed
- NCT04130490 — The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study · completed
- NCT04068818 — The Heidelberg Engineering ANTERION Imaging Agreement Study · completed
Other Heidelberg Engineering GmbH trials
Trials by the same sponsor.
- NCT07338461 — High Resolution Imaging OCT Study · NA · not yet recruiting
- NCT06397976 — The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study · terminated
- NCT05051813 — The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study · completed
- NCT04961398 — Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements · completed
- NCT04661124 — Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04083742 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heidelberg Engineering GmbH
- Last refreshed: 21 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04083742.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing